Best Income Companies To Watch For 2014

On this day in economic and business history ...

In most respects, April 28, 1942, was much like any other day of the Great Depression era for American markets. "The stock market lacked buying confidence today and leading issues retreated fractions of a point or more," wrote Associated Press journalist Bernard S. O'Hara. President Franklin D. Roosevelt's plan to limit personal incomes to an upper ceiling of $25,000 was greeted with a ho-hum response. When asked for his opinion, one stockbroker told The New York Times that "the President's message had just about the same effect as another sinking off the Atlantic Coast. Bad news has been discounted. Investment demand continues where it was, poor but reasonably steady."

No one knew it then, but that day was the last day of the longest, deepest slide in American market history. The Dow Jones Industrial Average (DJINDICES: ^DJI  ) finished April 28, 1942, at a closing value of 92.92 points. It was still 75% below an all-time high reached in the fall of 1929. At no time in those 13 years had the Dow reclaimed more than half the value it had lost from its 1929 peak of 381.17. But the very next day, the Dow began its recovery, and within weeks it had left single-digit territory behind for good.

10 Best Forestry Stocks To Own Right Now: Macy’s Inc (M)

Macy�s, Inc., together with its subsidiaries, operates stores and Internet Websites in the United States. Its retail stores and Internet Web sites sell a range of merchandise, including apparel and accessories for men, women, and children; cosmetics; home furnishings; and other consumer goods. The company also operates Bloomingdale�s Outlet stores that offer a range of apparel and accessories, including ready-to-wear, shoes, fashion accessories, jewelry, handbags, and intimate apparel products. As of January 28, 2012, it operated approximately 840 stores under the names of Macy�s and Bloomingdale�s; and 7 Bloomingdale�s Outlet stores, as well as macys.com and bloomingdales.com. The company was formerly known as Federated Department Stores, Inc. and changed its name to Macy�s, Inc. in June 2007. Macy�s, Inc. was founded in 1820 and is based in Cincinnati, Ohio.

Advisors' Opinion:

• [By Jon C. Ogg]

  Macy’s Inc. (NYSE: M) may not be a favorite among employees after news that it was laying off 2,500 workers and shutting five stores, but shares ended up at a new high after the company’s earnings guidance. Macy’s shares were trading up in the final minutes of the trading day.

• [By Sue Chang]

  Macy�� (M) �is projected to report first-quarter earnings of 59 cents a share, according to a consensus survey by FactSet. Expectations for the first quarter are subdued due to weather disruptions, with investors likely to focus their attention on details for April and May, analyst Charles Grom at Sterne Agee said in a note.

• [By WALLSTCHEATSHEET]

  Macy�� online performance over the past three months hasn�� been good. However, management has been making a lot of wise moves that should lead to investor rewards. While Macy�� wouldn�� be capable of withstanding a severe stock market correction, it�� one of the most well-run retailers in the industry. That being the case, as long the broader market holds, Macy�� should perform well. This is in addition to a generous 2.10 percent yield.

Best Income Companies To Watch For 2014: LVMH Moet Hennessy Louis Vuitton SA (LVMH)

LVMH Moet Hennessy Louis Vuitton SA, (LVMH), is a France-based luxury goods company. It owns a portfolio of luxury brands and its business activities are divided into five segments: Wines and Spirits, Fashion and Leather Goods, Perfumes and Cosmetics, Watches and Jewelry, and Selective Retailing. The activities of the wines and spirits sector include the Champagne and Wines branch, and the Cognac and Spirits branch. The Fashion and Leather Goods group includes Louis Vuitton, Kenzo and Rossimoda among others. LVMH is present in the perfume and cosmetics sector through the French Houses Christian Dior and other brands. Watches and Jewelry sells such products as TAG Heuer, Zenith, Dior Watches, Chaumet and Fred, among others. Selective Retailing businesses operate in two segments: travel retail and the seleLVMH ctive retail concepts represented by Sephora and Le Bon Marche. In September 2013, the Company acquired majority stake in Nicholas Kirkwood, a British shoe designer company. Advisors' Opinion:

• [By Holly LaFon]

  Louis Vuitton (LVMH) is one of the world's leading manufacturers and retailers of luxury apparel. Nearly two years ago, we began to analyze the company. We liked the business model, particularly the growth potential as consumers in emerging markets grow more eager to demonstrate their af铿�ence. We concluded that the company was well-run by a trustworthy management team, but its valuation did not seem very compelling. Louis Vuitton did not appear to be trading at what we felt was enough of a discount to its intrinsic value. Despite this, we did not abandon the idea. For the next 18 months we kept Louis Vuitton on what we call our inventory list. It was an investment we were comfortable making if the right price presented itself. In April, Louis Vuitton shares declined sharply after shareholders were disappointed by their latest earnings announcement, bringing the stock down to a valuation that we felt was attractive. We acted quickly to purchase shares.

• [By Holly LaFon]

  TR: It�� a one-off isn�� it? That�� why we said ��what could be the source of new ideas? We��e got Richemont, you have Louis Vuitton Mo毛t Hennessy (LVMH).

Best Income Companies To Watch For 2014: Polypore International Inc(PPO)

Polypore International, Inc., a technology filtration company, develops, manufactures, and markets specialized microporous membranes used in separation and filtration processes. It operates in two segments, Energy Storage and Separations Media. The Energy Storage segment offers membranes that provide the function of separating the cathode and anode in applications, including lithium-ion batteries that are used in portable electronic devices, energy storage systems, cordless power tools, and electric drive vehicles; and lead-acid batteries used in automobiles, other motor vehicles, forklifts, and uninterruptible power supply systems. The Separations Media segment provides membranes that are used as high technology filtration element in various medical and industrial applications. This segment?s membranes and membrane modules are used in applications, such as hemodialysis, blood oxygenation, plasmapheresis and various high-performance microfiltration, ultrafiltration, and g asification/degasification applications. Polypore International, Inc. sells its products to manufacturers and converters who incorporate its products into their finished goods. The company sells its products and services in North America, South America, Europe, and Asia through its direct sales force, and distributors and agents. The company is headquartered in Charlotte, North Carolina.

Advisors' Opinion:

• [By John Udovich]

  When most people think of electric vehicle stocks, they probably think of troubled Tesla Motors Inc (NASDAQ: TSLA) or one of the several Chinese stocks active in the space, but North America based large cap Magna International Inc (NYSE: MGA) and small caps Polypore International, Inc (NYSE: PPO), UQM Technologies Inc (NYSEMKT: UQM) and Green Automotive Company (OTCMKTS: GACR) are all players, one way or the other, in the electric vehicle space that most investors have probably overlooked or just aren�� aware of. Of course, we can argue�about whether or not purely electric vehicles or some sort of hybrid vehicles are the way of the future, but what cannot be argued about is the fact that the following electric vehicle stocks are at the forefront of EV or�hybrid technology and design:

Best Income Companies To Watch For 2014: Trovagene Inc (TROV)

TrovaGene, Inc. (TrovaGene), incorporated on April 26, 2002, is a development-stage molecular diagnostic company that focuses on the development and marketing of urine-based nucleic acid tests for patient/disease screening and monitoring. The Company's novel tests predominantly use transrenal DNA (Tr-DNA) and transrenal RNA (Tr-RNA). The Company's technology is used to all transrenal nucleic acids (Tr-NA). The Company�� urine-based test addresses market needs, such as women�� healthcare-fetal medicine-down syndrome, infectious diseases, cancer testing, transplantation, drug development and monitoring of therapeutic outcomes, ultra-sensitive analytical and detection system, technologies for the collection, shipment and storage of urine specimens, and transrenal nucleic acid extraction, and instrumentation/system platform.

On January 18, 2011, the Company entered into an asset purchase agreement pursuant to which the Company acquired a hybridoma able to produce a monoclonal antibody targeting the NPM1 biomarker. On February 8, 2011, the Company entered into a sublicense agreement with MLL Munchner Leukamielabor (MLL). In July, 2011, the Company entered into a sublicense agreement with Fairview Health Services (Fairview) for NPM1 patent rights.

In October 2011, the Company entered into a license agreement pursuant to which the Company licensed the patent rights to a specific gene mutation with respect to chronic lymphoblastic leukemia. On December 12, 2011, the Company entered into a license agreement pursuant to which the Company licensed the patent rights to hairy cell leukemia biomarkers. On February 1, 2012, the Company acquired the clinical laboratory improvement amendments (CLIA) laboratory assets of MultiGEN Diagnostics, Inc. (MultiGEN).

Advisors' Opinion:

• [By David Goodboy]

  Fortunately, diagnostic issues may soon be a thing of the past. Several publicly traded companies are currently making great strides in the field of medical diagnostics, and my favorite company right now in that arena is TrovaGene (Nasdaq: TROV).

• [By Daniel Lauchheimer]

  In the past few weeks, I wrote two articles about TrovaGene (TROV) -- one detailing the history of the DNA market generally and the molecular diagnostics -- and TROV's place therein -- market specifically, and the second detailing the company's internal valuation. In this article, I will value TROV on an external, relative basis. Specifically, I will compare TROV to another molecular diagnostics company, Exact Sciences (EXAS), and try to show that while the market seems to have given EXAS a fair shake, it has not done the same for TROV. I will prove this argument by looking at both companies' addressable markets, and their respective progress at bringing the products to market. However, before we take this deep dive into both companies, I will take a moment to review each of the companies' products, so we have a strong background before turning to the deeper analysis.